Description Our bioactive VEGF-165 Rat, E. coli Recombinant Protein is a double, non-glycosylated, polypeptide chain that contains 165 amino acids and has a molecular mass of 38,750 Dalton. The VEGF-165 is purified by proprietary chromatographic techniques. Summary Vascular endothelial growth factor (VEGF), also known as VEGF-A, is an important signaling protein involved in both vasculogenesis and angiogenesis. As its name implies, VEGF activity has been mostly studied on cells of the vascular endothelium, although it does have effects on a number of other cell types (e.g. stimulation monocyte/macrophage migration, neurons, cancer cells, kidney epithelial cells ). VEGF mediates increased vascular permeability, induces angiogenesis, vasculogenesis and endothelial cell growth, promotes cell migration, and inhibits apoptosis. In vitro, VEGF has been shown to stimulate endothelial cell mitogenesis and cell migration. VEGF is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternately spliced VEGF isoforms of 121, 145, 165, 183, 189, and 206 amino acids (aa) are expressed in humans, with VEGF-165 being known to be the most abundant and potent isoform. CAS Registry No. 127464-60-2 Other Names VEGF-A, VEGFA, Vascular endothelial growth factor (VEGF), Vascular Endothelial Growth Factor 165, VEGF165, VEGF 165, Vascular permeability factor (VPF), UniProtKB# P16612. Source Expressed in E. coli. Formulation Sterile-filtered, white, lyophilized (freeze-dried) powder. Rat VEGF-165 protein was lyophilized from 10 mM NaP, pH 7.5. Amino Acid Sequence MAPTTEGEQK AHEVVKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC CNDEALECVP TSESNVTMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR. Purity Purity greater than 97.0% as determined by: Analysis by RP-HPLC. Analysis by SDS-PAGE. Biological Activity Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 4.0-8.0 ng/ml. Reconstitution It is recommended to reconstitute the lyophilized VEGF-165 in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. Shipping Ships at ambient temperature. Upon receipt, store the product at the temperature recommended below. Storage/Expiration Lyophilized VEGF-165, although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution, VEGF-165 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. Usage This product is intended for Laboratory Research Use Only. Not for use in diagnostic or therapeutic procedures. This product may not be used as a pharmaceutical or veterinary drug, agricultural product, or food additive. Documents Product Datasheet (PDS) Related Products Cytokines & Growth Factors ISOkine® VEGF-165 Human, Animal-Free Recombinant Protein Anti-VEGF Human Recombinant Antibody VEGF-165 Human, E. coli Recombinant Protein VEGF-165 Mouse, E. coli Recombinant Protein
